Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Grant to SDSU researcher will address congestive heart failure

John M. Robinson MD, PhD., Assistant Professor
John M. Robinson MD, PhD., Assistant Professor

Abstract:
A grant of about $1.8 million over five years will help scientists better understand congestive heart failure, a condition that affects 5.7 million Americans annually.

Grant to SDSU researcher will address congestive heart failure

Brookings, SD | Posted on December 21st, 2010

John Robinson, a medical doctor and biophysicist at South Dakota State University, has been awarded the funding by the Heart, Lung and Blood Institute of the National Institutes of Health. The research could supply new knowledge about heart failure that could lead to new treatment strategies.

The risk of congestive heart failure increases sharply with age, doubling every 10 years among older adults. At younger ages, blacks are disproportionately affected compared to whites by a ratio of 20 to 1.

Robinson, a member of the Department of Chemistry and Biochemistry in SDSU's College of Arts and Sciences, is especially interested in heart failure in connection with impaired function of the myofilament, a protein assembly regulated by calcium that makes the heart contract.

"The myofilament is the fundamental unit that allows the heart to generate force. Your heart has to beat and relax about once every second," Robinson said. "These periods of contraction and relaxation are regulated by the levels of calcium inside cells of the heart. The myofilament is a calcium-sensitive switch that generates force when calcium binds to it."

However, scientists don't fully understand how the myofilament functions or what goes wrong when it doesn't work properly. Robinson said that's because those processes are taking place at the nanoscale, or roughly at a level 100 to 1,000 times smaller than can be seen by using a conventional microscope.

"Switching in the nanoscale is very different from switching in our world. If I turn a light switch on, it stays on," Robinson said. "What we're seeing with protein switches is that just because calcium binds to it, it will not necessarily turn on. It's sort of error-prone. All of the switching is done by heat random collisions with water is what drives all of this."

Robinson said a revolution in instrumentation is making it possible to unravel such processes, some of which have been studied for decades. Robinson is part of the SDSU-based Center for Biological Control and Analysis by Applied Photonics, or BCAAP. The center is made up of researchers who use light as one of the tools either to control biochemical processes or, in this case, to analyze biochemical processes.

Robinson's laboratory uses a technique called Fluorescence Resonance Energy Transfer, or FRET, to study proteins at the nanoscale. His FRET measurements are at the "single molecule" level, studying myofilaments one at a time.

Robinson's five-year NIH project will work to establish what molecular interactions are taking place as the myofilament contracts; and to understand the mechanisms at work when myofilaments' sensitivity to calcium is altered.

####

For more information, please click here

Copyright © South Dakota State University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Govt.-Legislation/Regulation/Funding/Policy

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Researchers develop microbubble scrubber to destroy dangerous biofilms September 19th, 2018

Researchers managed to prevent the disappearing of quantum information September 14th, 2018

New photonic chip promises more robust quantum computers September 14th, 2018

Academic/Education

The Institute of Applied Physics at the University of Tsukuba near Tokyo in Japan uses Deben's ARM2 detector to better understand catalytic reaction mechanisms June 27th, 2018

Powering the 21st Century with Integrated Photonics: UCSB-Led Team Selected for Demonstration of a Novel Waveguide Platform Which is Transparent Throughout the MWIR and LWIR Spectral Bands June 19th, 2018

SUNY Poly Professor Eric Lifshin Selected for ‘Fellow of the Microanalysis Society’ Position for Significant Contributions to Microanalysis June 13th, 2018

Grand Opening of UC Irvine Materials Research Institute (IMRI) to Spotlight JEOL Center for Nanoscale Solutions: Renowned Materials Scientists to Present at the 1st International Symposium on Advanced Microscopy and Spectroscopy (ISAMS) April 18th, 2018

Nanomedicine

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Tools

Carbon nanodots do an ultrafine job with in vitro lung tissue: New experiments highlight the role of charge and size when it comes to carbon nanodots that mimic the effect of nanoscale pollution particles on the human lung. September 12th, 2018

Terahertz spectroscopy enters the single-molecule regime September 7th, 2018

Mirrorcle Demonstrates MEMS-based Programmable Light Source at CES and PW18 August 30th, 2018

Stress-free ALD from Picosun August 28th, 2018

Nanobiotechnology

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project